
Celtis Pharmaceuticals India Private Limited
About Celtis Pharmaceuticals India Private Limited
Data last updated:
Celtis Pharmaceuticals India Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the repair services segment of the electronics sector. It was incorporated on 24 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U52609HR2018PTC076599.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.05 Lakh. It is led by directors including Bina Chaudhri and Rajni Maurya.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gali No 2 Block D Basantpur Ismailpur Amamagar Amarnagar Faridabad, Haryana, India – 121003.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.29 Lakh. For the same year it recorded a net loss of ₹23,720 (net margin -18.4%) and EBITDA of -₹21,935 (EBITDA margin -17%).
Company details
Contact details
Celtis Pharmaceuticals India Private Limited's registered office is in Faridabad, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressGali No 2 Block D Basantpur Ismailpur Amamagar Amarnagar Faridabad, Haryana, India – 121003
- IndustryElectrnoics, Repair Services
To see the full contact details of Celtis Pharmaceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Celtis Pharmaceuticals India Private Limited
FY 2025 filings availableCeltis Pharmaceuticals India Private Limited reported revenue of ₹1.29 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹21,935 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹23,720 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17% | ||||
| Net Profit Margin | -18.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Celtis Pharmaceuticals India Private Limited, buy the company report.
Board of directors of Celtis Pharmaceuticals India Private Limited
Celtis Pharmaceuticals India has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poonam Shitalaprasad Yadav | Additional Director | 26 Sep 2024 | 2 Years 1 Months | Current |
| Bina Chaudhri | Director | 24 Oct 2018 | 8 Years 0 Months | Current |
| Rajni Maurya Also directs: Daily Cure Naturals LLP, Wildvedic Naturals Private Limited | Director | 24 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Celtis Pharmaceuticals India Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gayatri Pharmaceuticals Pvt Ltd | ₹1.35 Lakh (FY 2025) | -24.0% | Cuttack, Odisha, India | |||
| Parisar Pharmaceuticals Private Limited | ₹1.35 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Leaxon Pharmaceuticals Private Limited | ₹1.34 Lakh (FY 2021) | Bareiily, Uttar Pradesh, India | ||||
| Adoshine Pharmaceuticals Private Limited | ₹1.32 Lakh (FY 2025) | 777.0% | New Delhi, Delhi, India | |||
| Silva Pharmaceuticals Private Limited | ₹1.3 Lakh (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Celtis Pharmaceuticals India Private Limitedthis company | ₹1.29 Lakh (FY 2025) | -₹23,720 | -18.4% | Faridabad, Haryana, India | ||
| Uptrimis Pharmaceuticals Private Limited | ₹1.28 Lakh (FY 2025) | 81.0% | Lucknow, Uttar Pradesh, India | |||
| Zoofin Pharmaceuticals Private Limited | ₹1.28 Lakh (FY 2025) | -15.0% | Chandigarh, India | |||
| Synodor Pharmaceuticals Private Limited | ₹1.27 Lakh (FY 2025) | -45.0% | Aurangabad, Maharashtra, India | |||
| Nuwsm Pharmaceuticals Private Limited | ₹1.27 Lakh (FY 2021) | -72.0% | Nagpur, Maharashtra, India | |||
| Za1 Pharmaceuticals Private Limited | ₹1.26 Lakh (FY 2025) | 99.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Celtis Pharmaceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Celtis Pharmaceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celtis Pharmaceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Celtis Pharmaceuticals India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Celtis Pharmaceuticals India Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Poonam Shitalaprasad Yadav was appointed as Additional Director on 26 Sep 2024.
Frequently asked questions
Celtis Pharmaceuticals India is an active private limited company based in Faridabad, Haryana, India. The company works in repair services, within the electronics industry. It was incorporated on 24 October 2018 (8+ years old) and is registered under CIN U52609HR2018PTC076599.
Celtis Pharmaceuticals India has 3 current directors:
- Poonam Shitalaprasad Yadav - Additional Director
- Bina Chaudhri - Director
- Rajni Maurya - Director
The latest financial statements of Celtis Pharmaceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Celtis Pharmaceuticals India is U52609HR2018PTC076599. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celtis Pharmaceuticals India was incorporated on 24 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Celtis Pharmaceuticals India by revenue are Gayatri Pharmaceuticals Pvt Ltd, Parisar Pharmaceuticals Private Limited, Leaxon Pharmaceuticals Private Limited, Adoshine Pharmaceuticals Private Limited, Silva Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Poonam Shitalaprasad Yadav was appointed as Additional Director on 26 Sep 2024. Poonam Shitalaprasad Yadav ceased to be Director on 15 Apr 2019. Bina Chaudhri was appointed as Director on 24 Oct 2018. Celtis Pharmaceuticals India has 4 board changes on record in total.
The registered office of Celtis Pharmaceuticals India is at Gali No 2 Block D Basantpur Ismailpur Amamagar Amarnagar Faridabad, Haryana, India – 121003.
Celtis Pharmaceuticals India operates in the electronics industry, in the repair services segment.
Celtis Pharmaceuticals India can be reached at its registered office: Gali No 2 Block D Basantpur Ismailpur Amamagar Amarnagar Faridabad, Haryana, India – 121003.
Celtis Pharmaceuticals India is registered under the jurisdiction of the Registrar of Companies (ROC), Haryana.

